Señales en vivo de 6669.HK | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 03:52):

Stats
Volumen de hoy	286 000
Volumen promedio	249 932
Capitalización de mercado	2.03B
EPS	HKD0 ( 2024-03-25 )
Próxima fecha de ganancias	( HKD0 ) 2024-06-28
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	125.20
ATR14	HKD0.0270 (0.43%)

Volumen Correlación

Largo: -0.06 (neutral)

Corto: 0.78 (moderate)

Signal:(31.163) Neutral

Acotec Scientific Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acotec Scientific Correlación - Moneda/Commodity

0.55
( weak )

0.41
( neutral )

0.00
( neutral )

0.45
( neutral )

0.24
( neutral )

-0.83
( strong negative )

Acotec Scientific Finanzas

Annual	2023
Ingresos:	HKD473.85M
Beneficio Bruto:	HKD377.42M (79.65 %)
EPS:	HKD0.0481

FY	2023
Ingresos:	HKD473.85M
Beneficio Bruto:	HKD377.42M (79.65 %)
EPS:	HKD0.0481

FY	2022
Ingresos:	HKD395.55M
Beneficio Bruto:	HKD336.35M (85.04 %)
EPS:	HKD0.230

FY	2021
Ingresos:	HKD303.81M
Beneficio Bruto:	HKD265.94M (87.53 %)
EPS:	HKD-0.252

Financial Reports:

No articles found.

Acotec Scientific

Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally. It offers AcoArt Orchid & Dhalia to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company also provides AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited is a subsidiary of CA Medtech Investment (Cayman) Limited.